Evidence Level
GABA supplementation remains somewhat controversial due to the longstanding assumption that GABA cannot cross the blood-brain barrier. However, recent evidence suggests limited BBB permeability, and clinical effects are consistently demonstrated. Abdou et al. (2006) provided EEG evidence of alpha wave increases within 60 minutes of 200mg GABA. Nakamura et al. (2009) showed PharmaGABA reduced salivary stress markers during a controlled stress task. Yamatsu et al. (2016) demonstrated sleep benefits with 100mg PharmaGABA. The mechanism may involve peripheral GABA receptors in the enteric nervous system (gut-brain axis), partial BBB penetration, or effects on the vagus nerve. PharmaGABA consistently outperforms synthetic GABA in studies, possibly due to its natural L-isomer configuration.